CheckMyRecalls

Padagis US LLC recalls Nystatin Cream USP

Published
22 Jul 2026
Units affected
180,936 tubes
Agency
FDA
Country
United States

The hazard

Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35

Brand / company
Padagis US LLC
Codes / lots
Lot #: 205060, Exp 09/30/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.